PGE2 and dibutyryl cyclic adenosine monophosphate prolong eosinophil survival in vitro

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 1, 1999, Pages 153-162

  Peacock, Craig D ^a   Misso, Neil L A ^a   Watkins, D Neil ^a   Thompson, Philip J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Annexin V; Apoptosis; Asthma; Eosinophil; Fas; IL 5; PGE2; TNF

Indexed keywords

11 DEOXYPROSTAGLANDIN E1; 2,2' (HYDROXYNITROSOHYDRAZONO) BIS ETHANAMINE; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DIBUTYRYL CYCLIC GMP; DNA FRAGMENT; FAS ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 5; LIPOCORTIN 5; MONOCLONAL ANTIBODY; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; PHOSPHATIDYLSERINE; PHOSPHORUS 32; PROPIDIUM IODIDE; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DIPLOIDY; EOSINOPHIL; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDIATOR; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0032840848     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70127-2     Document Type: Article

References (52)

1. 1. Reed CE. New therapeutic approaches in asthma. J Allergy Clin Immunol 1986;77:537-43.
2. 2. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
3. 3. Baigelman W, Chodosh S, Pizzuto D, Cupples LA. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. Am J Med 1983;75:929-36.
4. 4. Diaz P, Galleguillos FR, Gonzalez MC, Pantin CF, Kay AB. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. J Allergy Clin Immunol 1984;74:41-8.
5. 5. Taylor KA, Luksza PR. Peripheral blood eosinophil counts and bronchial hyperresponsiveness. Thorax 1987;42:452-6.
6. 6. Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PM. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle: role of the epithelium. Am Rev Respir Dis 1988;138:685-8.
7. 7. Hastie AT, Loegering DA, Gleich GJ, Kueppers F. The effect of purified human eosinophil major basic protein on mammalian ciliary activity. Am Rev Respir Dis 1987;135:848-53.
8. 8. Tai PC, Sun L, Spry CJF. Effects of IL-5, granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 1991;85:312-6.
9. 9. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992;148:3543-9.
10. 10. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996;156:4422-8.
11. 11. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
12. 12. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995;86:1437-43.
13. 13. Druilhe A, Cai Z, Haile S, Chouaib S, Pretolani M. Fas-mediated apoptosis in cultured human eosinophils. Blood 1996;87:2822-30.
14. 14. Yasui K, Hu B, Nakazawa T, Agematsu K, Komiyami A. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest 1997;100:1677-84.
15. 15. Hebestreit H, Dibbert B, Balatti I, Braun D, Schapowal A, Blaser K, et al. Disruption of Fas receptor signaling by nitric oxide in eosinophils. J Exp Med 1998;187:415-25.
16. 16. Knight DA, Stewart GA, Thompson PJ. The respiratory epithelium and airway smooth muscle homeostasis. Clin Exp Allergy 1994;24:698-706.
17. 17. Alam R, Dejarnatt A, Stafford S, Forsythe PA, Kumar D, Grant JA. Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misoprostol, a PGE analog: results of a double-blind, placebo-controlled randomized study. Am Rev Respir Dis 1993;148:1066-70.
18. 18. Teixeira MM, al-Rashed S, Rossi AG, Hellewell PG. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils. Br J Pharmacol 1997;121:77-82.
19. 19. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT. Regulation of Ig-induced eosinophil degranulation by adenosine 3′5′-cyclic monophosphate. J Immunol 1991;146:2712-8.
20. 20. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am Rev Respir Dis 1994;149:538-51.
21. 21. Watkins DN, Peroni DJ, Basclain KA, Garlepp MJ, Thompson PJ. Expression and activity of nitric oxide synthases in human airway epithelium. Am J Respir Cell Mol Biol 1997;16:629-39.
22. 22. Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995;16:128-30.
23. 23. del Pozo V, de Arruda-Chaves E, de Andres B, Cardaba B, Lopez-Farre A, Gallardo S, et al. Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. J Immunol 1997;158:859-64.
24. 24. Ferreira HH, Medeiros MV, Lima CS, Flores CA, Sannomiya P, Autunes E, et al. Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis. Eur J Pharmacol 1996;310:201-7.
25. 25. Arock M, Le Goff L, Becherel PA, Dugas B, Debre P, Mossalayi MD. Involvement of Fc epsilon RII/CD23 and L-arginine dependent pathway in IgE-mediated activation of human eosinophils. Biochem Biophys Res Commun 1994;30:265-71.
26. 26. Silberstein DS, David JR. Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc Natl Acad Sci USA 1986;83:1055-9.
27. 27. Nagata M, Fukuda T, Numao T, Makino S, Dohi Y. Tumor necrosis factor alpha induces migration of human eosinophils. Arerugi 1993;42:549-55.
28. 28. Lukacs NW, Strieter RM, Chensue SW, Widmer M, Kunkel SL. TNF-α mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol 1995;154:5411-7.
29. 29. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-9.
30. 30. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, Schie RCAA, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545-56.
31. 31. Misso NLA, Peroni DJ, Watkins DN, Stewart GA, Thompson PJ. Glutathione peroxidase activity and mRNA expression in eosinophils and neutrophils of asthmatic and non-asthmatic subjects. J Leukocyte Biol 1998;63:124-30.
32. 32. Tilly JL, Hsueh AJ. Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J Cell Physiol 1993;154:519-26.
33. 33. Coleman RA, Smith WL, Narumiya S. Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-29.
34. 34. Rossi AG, Cousin JM, Dransfield I, Lawson MF, Chilvers ER, Haslett C. Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem Biophys Res Commun 1995;217:892-9.
35. 35. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012-20.
36. 36. Schmidt HH, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1993;1178:153-75.
37. 37. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-19.
38. 38. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ. Differential expression of Fas (CD95) and fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 1996;184:429-40.
39. 39. Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y. Mast cells enhance eosinophil survival in vitro: role of TNF-α and granulocyte-macrophage colony-stimulating factor. J Immunol 1998;160:5554-62.
40. 40. Hallsworth MP, Giembycz MA, Barnes PJ, Lee TH. Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF. Br J Pharmacol 1996;117:79-86.
41. + T lymphoblasts. J Immunol 1995;154:1041-7.
42. 42. Mischak H, Seitz T, Janosch P, Eulitz M, Steen H, Schellerer M, et al. Negative regulation of Raf-1 by phosphorylation of serine 621. Mol Cell Biol 1996;16:5409-18.
43. 43. Parvathenani LK, Buescher ES, Chacon-Cruz E, Beebe SJ. Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3. J Biol Chem 1998;273:6736-43.
44. 44. Pazdrak K, Olszewska-Pazdrak B, Stafford S, Garofalo RP, Alam R. Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J Exp Med 1998;188:421-9.
45. 45. Hiraguri M, Miike S, Sano H, Kurasawa K, Saito Y, Iwamoto I. Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils. J Allergy Clin Immunol 1997;100:S45-S51.
46. 46. Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of Lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J Exp Med 1995;181:1827-34.
47. 47. Hafner S, Adler HS, Mischak H, Janosch P, Heidecker G, Wolfman A, et al. Mechanism of inhibition of Raf-1 by protein kinase A. Mol Cell Biol 1994;14:6696-703.
48. 2. Lancet 1994;344:436-8.
49. 49. Beauvais F, Michel L, Dubertret L. The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils. FEBS Lett 1995;361:229-32.
50. 50. Hannah S, Nadra I, Dransfield I, Pryde JG, Rossi AG, Haslett C. Constitutive neutrophil apoptosis in culture is modulated by cell density independently of β2 integrin-mediated adhesion. FEBS Lett 1998;421:141-6.
51. 51. Collins JA, Schandl CA, Young KK, Vesely J, Willingham MC. Major DNA fragmentation is a late event in apoptosis. J Histochem Cytochem 1997;45:923-34.
52. 52. Simon H-U. Eosinophil apoptosis in allergic diseases: an emerging new issue. Clin Exp Allergy 1998;28:1321-4.